Potential role of Bcl-2 expression and apoptotic body index in colorectal cancer

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 76-81

  El Awady, Saleh ^a   Morshed, Mosad ^a   El Shobaky, Mohamed ^a   Abo Hashem, Maha ^a   Ghazy, Hosam ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Apoptosis; Bcl 2; Colorectal cancer

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; ASSAY; BIVARIATE ANALYSIS; CANCER PATIENT; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; GASTROINTESTINAL BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RATING SCALE; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; APOPTOSIS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 41549121443     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hayne D, Brown RS, McCormack M, Quinn MJ, Payne HA, Babb P: Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) 2001; 13(6):448-452.
2. Sherif M, Ibrahim AS: The profile of cancer in Egypt. Arab World Printing House, Cairo, 1987.
3. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2001; 2(9):533-543. Erratum in: Lancet Oncol 2001; 2(10):596.
4. American Joint Committee on Cancer: AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.
5. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, et al: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342(2):69-77.
6. Brajuskovic GR: Apoptosis in malignant disease. Arch Oncol(2005):; 13(1): 19-22.
7. Shtivelman E: A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene 1997; 14(18):2167-2173.
8. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229(4720):1390-1393.
9. Lawen A: Apoptosis-an introduction. Bioessays 2003; 25(9):888-896.
10. Eastman A, Grant S, Lock R, Tritton T, Van Houten N, Yuan J: Cell death in cancer and development. AACR special conference in cancer research. Cancer Res 1994; 54(10):2812-2818.
11. Kerr JF, Winterford CM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73(8):2013-2026. Review. Erratum in: Cancer 1994; 73(12):3108.
12. Earnshaw WC: Apoptosis. A cellular poison cupboard. Nature 1999; 397(6718):387-389.
13. Sobin LH, Wittekind CH: TNM classification of malignant tumours. A JOHN Wiley and Sons; Inc., Publication; 1997; pp. 66-70.
14. Saegusa M, Okayasu I: Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas. J Pathol 1997; 182(4):429-436.
15. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119(3):493-501.
16. Lipponen P, Aaltomaa S: Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 1994, 173:333-339.
17. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999; 49(1):8-31.
18. Khafagy W, El-Ghazaly M, El-Shobaky M, Khafagy M: Colorectal cancer in Egypt - Does it differ? Coloproctology 2000; 22(3):109-115.
19. Soliman AS, Bondy ML, El-Badawy SA, Mokhtar N, Eissa S, Bayoumy S, et al: Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer 2001; 85(7):1037-1046.
20. OPC (Office of Population Census) (1997): Cairo: Central Agency for Public Mobilization and Statistics, 1996.
21. Johansen C, Mellemgaard A, Skov T, Kjaergaard J, Lynge E: Colorectal cancer in Denmark 1943-1988. Int J Colorectal Dis 1993; 8(1):42-47.
22. Adib SM, Mufarrij AA, Shamseddine AI, Kahwaji SG, Issa P, el-Saghir NS: Cancer in Lebanon: an epidemiological review of the American University of Beirut Medical Center Tumor Registry (1983-1994). Ann Epidemiol 1998; 8(1):46-51.
23. Abou-Zeid AA, Khafagy W, Marzouk DM, Alaa A, Mostafa I, Ela MA: Colorectal cancer in Egypt. Dis Colon Rectum 2002; 45(9):1255-1260.
24. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J: Molecular biology of colorectal cancer. Curr Probl Cancer 1997; 21(5):233-300.
25. Bosari S, Moneghini L, Graziani D, Lee AK, Murray JJ, Coggi G, Viale G: bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol 1995; 26(5):534-540.
26. Pereira H, Silva S, Juliao R, Garcia P, Perpetua F: Prognostic markers for colorectal cancer: expression of P53 and BCL2. World J Surg 1997; 21(2):210-213.
27. Zhao DP, Ding XW, Peng JP, Zheng YX, Zhang SZ: Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma. J Zhejiang Univ Sci B 2005; 6(12):1163-1169.
28. Baretton GB, Diebold J, Christoforis G, Vogt M, Muller C, Dopfer K, et al: Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 1996; 77(2):255-264.
29. Mullauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A: Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res 2001; 488(3):211-231.
30. Scopa CD, Tsamandas AC, Zolota V, Kalofonos HP, Batistatou A, Vagianos C: Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study. Dig Dis Sci. 2003; 48(10):1990-1997.
31. Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M, et al; North Central Cancer Treatment Group: Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol 2004; 22(9):1572-1582.
32. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW: Colorectal cancer. Lancet 2005; 365(9454):153-165.
33. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, et al: Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 1997; 74(3):346-358.
34. Watson NF, Madjd Z, Scrimegour D, Spendlove I, Ellis IO, Scholefield JH, Durrant LG: Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients. World J Surg Oncol 2005; 3:47.
35. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124(1-2):1-6.
36. Aotake T, Lu CD, Chiba Y, Muraoka R, Tanigawa N: Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis. Clin Cancer Res 1999; 5(1):135-142.
37. Katsumata K, Sumi T, Tomioka H, Aoki T, Koyanagi Y: Induction of apoptosis by p53, bax, bcl-2, and p21 expressed in colorectal cancer. Int J Clin Oncol 2003; 8(6):352-356.
38. Elkablawy MA, Maxwell P, Williamson K, Anderson N, Hamilton PW: Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival. J Pathol 2001; 194(4):436-443.
39. Watson AJ: Apoptosis and colorectal cancer. Gut 2004; 53(11):1701-1709.
40. Bannura G, Cumsille MA, Contreras J, Melo C, Barrera A, Reinero M, Pardo L: [Prognostic factors in colorectal neoplasm. Multivariate analysis in 224 patients] Rev Med Chil 2001; 129(3):237-246. (In Spanish) (Abstract)
41. Olson RM, Perencevich NP, Malcolm AW, Chaffey JT, Wilson RE: Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980; 45(12):2969-2974.
42. Leahy DT, Mulcahy HE, O'Donoghue DP, Parfrey NA: bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology. 1999 Oct;35(4):360-7.
43. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, Vogelstein B: Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res 1994; 54(14):3714-3717.
44. Raff MC: Social controls on cell survival and cell death. Nature 1992; 356(6368):397-400.
45. Langlois NE, Lamb J, Eremin O, Heys SD: Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997; 182(4):392-397.
46. Schwandner O, Schiedeck TH, Bruch HP, Duchrow M, Windhoevel U, Broll R: Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables. Dis Colon Rectum 2000; 43(9):1227-1236.